Wells Fargo’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $454K | Buy |
|
|||||
|
2025
Q2 | $286K | Buy |
|
|||||
|
2025
Q1 | $264K | Buy |
|
|||||
|
2024
Q4 | $171K | Buy |
|
|||||
|
2024
Q3 | $181K | Sell |
|
|||||
|
2024
Q2 | $188K | Buy |
|
|||||
|
2024
Q1 | $173K | Buy |
|
|||||
|
2023
Q4 | $133K | Buy |
|
|||||
|
2023
Q3 | $71.6K | Sell |
|
|||||
|
2023
Q2 | $95.3K | Buy |
|
|||||
|
2023
Q1 | $43.7K | Buy |
|
|||||
|
2022
Q4 | $8.38K | Sell |
|
|||||
|
2022
Q3 | $134K | Sell |
|
|||||
|
2022
Q2 | $94K | Sell |
|
|||||
|
2022
Q1 | $203K | Sell |
|
|||||
|
2021
Q4 | $284K | Sell |
|
|||||
|
2021
Q3 | $1.4M | Sell |
|
|||||
|
2021
Q2 | $2.07M | Buy |
|
|||||
|
2021
Q1 | $779K | Sell |
|
|||||
|
2020
Q4 | $726K | Sell |
|
|||||
|
2020
Q3 | $627K | Buy |
|
|||||
|
2020
Q2 | $578K | Buy |
|
|||||
|
2020
Q1 | $292K | Sell |
|
|||||
|
2019
Q4 | $773K | Sell |
|
|||||
|
2019
Q3 | $513K | Buy |
|
|||||
|
2019
Q2 | $791K | Buy |
|
|||||
|
2019
Q1 | $990K | Buy |
|
|||||
|
2018
Q4 | $682K | Buy |
|
|||||
|
2018
Q3 | $598K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2015
Q4 | $0 | Hold |
|
|||||
|
2015
Q3 | $0 | Sell |
|
|||||
|
2015
Q2 | $4K | Buy |
|